{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:06:19Z","timestamp":1786989979545,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jaad.2015.02.1121","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T08:46:04Z","timestamp":1427618764000},"page":"138-143.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Assessment of rosacea severity: A review of evaluation methods used in clinical trials"],"prefix":"10.1016","volume":"73","author":[{"given":"Dennis","family":"Hopkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Moradi Tuchayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Alinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2015.02.1121_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.02.1121_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaad.2004.04.013","article-title":"Measurement of the severity of rosacea","volume":"51","author":"Bamford","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.02.1121_bib3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archderm.134.4.508","article-title":"Interobserver variation in the assessment of rosacea","volume":"134","author":"Bamford","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1121_bib4","first-page":"34","article-title":"A\u00a0system for grading rosacea severity","volume":"133","author":"Henderson","year":"1995","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.02.1121_bib5","first-page":"907","article-title":"Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.02.1121_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/srt.12075","article-title":"Erythema dose\u2013a novel global objective index for facial erythema by computer-aided image analysis","volume":"20","author":"Choi","year":"2014","journal-title":"Skin Res Technol"},{"issue":"3","key":"10.1016\/j.jaad.2015.02.1121_bib7","first-page":"573","article-title":"Enhancing effect of pretreatment with topical niacin in the treatment of rosacea-associated erythema by 585-nm pulsed dye laser in Koreans: a randomized, prospective, split-face trial","volume":"164","author":"Kim","year":"2011","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.02.1121_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1346-8138.1999.tb03458.x","article-title":"The SAPASI is valid and responsive to psoriasis disease severity changes in a multi-center clinical trial","volume":"26","author":"Fleischer","year":"1999","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.02.1121_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2013.04.015","article-title":"Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: a double-blind randomized controlled trial","volume":"69","author":"Alam","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.02.1121_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1248\/cpb.60.583","article-title":"Preparation and evaluation of topical microemulsion system containing metronidazole for remission in rosacea","volume":"60","author":"Tirnaksiz","year":"2012","journal-title":"Chem Pharm Bull"},{"issue":"3","key":"10.1016\/j.jaad.2015.02.1121_bib11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","article-title":"Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicenter, randomized and vehicle-controlled studies","volume":"166","author":"Fowler","year":"2012","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.02.1121_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0091270010391533","article-title":"Evaluation of the efficacy and tolerance of a topical gel with 4% quassia extract in the treatment of rosacea","volume":"52","author":"Ferrari","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jaad.2015.02.1121_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1473-2165.2012.00623.x","article-title":"Clinical efficacy of a serum integrating multiple cosmetic ingredients in the management of erythema of the face in aging skin","volume":"11","author":"Dupont","year":"2012","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2015.02.1121_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1473-2165.2011.00598.x","article-title":"Clinical and instrumental assessment of the effects of a new product based on hydroxypropyl chitosan and potassium azeloyl diglycinate in the management of rosacea","volume":"11","author":"Berardesca","year":"2012","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.02.1121_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-4632.2011.05353.x","article-title":"Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea","volume":"51","author":"Bamford","year":"2012","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.02.1121_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/15569527.2010.541398","article-title":"Efficacy of 1% terbinafine cream in comparison with 0.75% metronidazole gel for the treatment of papulopustular rosacea","volume":"30","author":"Serdar","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"issue":"12","key":"10.1016\/j.jaad.2015.02.1121_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1346-8138.2011.01223.x","article-title":"Pimecrolimus 1% cream for\u00a0the treatment of rosacea","volume":"38","author":"Kim","year":"2011","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.02.1121_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2230.2009.03427.x","article-title":"A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial","volume":"35","author":"Koca","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.02.1121_bib19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1524-4725.2009.01156.x","article-title":"Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea","volume":"35","author":"Neuhaus","year":"2009","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jaad.2015.02.1121_bib20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2133.2008.08702.x","article-title":"Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results","volume":"159","author":"Papageorgiou","year":"2008","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.02.1121_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2008.02589.x","article-title":"A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea","volume":"22","author":"Karabulut","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2015.02.1121_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1473-2165.2008.00355.x","article-title":"Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation","volume":"7","author":"Berardesca","year":"2008","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.02.1121_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","article-title":"Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial","volume":"47","author":"Akhyani","year":"2008","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2015.02.1121_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2230.2007.02513.x","article-title":"Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea","volume":"32","author":"Wu","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2015.02.1121_bib25","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.02.1121_bib26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2015.02.1121_bib27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1468-3083.2007.02219.x","article-title":"Photodynamic therapy in a series of rosacea patients","volume":"21","author":"Bryld","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.jaad.2015.02.1121_bib28","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-4632.2006.02944.x","article-title":"Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study","volume":"45","author":"Sharquie","year":"2006","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.02.1121_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1468-3083.2005.01248.x","article-title":"Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea","volume":"19","author":"Rigopoulos","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2015.02.1121_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4632.2004.02130.x","article-title":"Adapalene vs. metronidazole gel for the treatment of rosacea","volume":"44","author":"Altinyazar","year":"2005","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2015.02.1121_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/09546630410033808","article-title":"A topical azithromycin preparation for the treatment of acne vulgaris and rosacea","volume":"15","author":"McHugh","year":"2004","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.jaad.2015.02.1121_bib32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-4632.2004.02283.x","article-title":"Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide\/clindamycin topical gel in the treatment of patients with moderate to severe rosacea","volume":"43","author":"Breneman","year":"2004","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2015.02.1121_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-4632.2004.01958.x","article-title":"Therapeutic potential of azithromycin in rosacea","volume":"43","author":"Bakar","year":"2004","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2015.02.1121_bib34","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","article-title":"A comparison of 15%\u00a0azelaic acid gel and 0.75% metronidazole gel in the\u00a0topical treatment of papulopustular rosacea: results of\u00a0a randomized trial","volume":"139","author":"Elewski","year":"2003","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2015.02.1121_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000065849","article-title":"Permethrin 5%\u00a0cream versus metronidazole 0.75% gel for the treatment\u00a0of papulopustular rosacea. A randomized double-blind placebo-controlled study","volume":"205","author":"Kocak","year":"2002","journal-title":"Dermatology"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2015.02.1121_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000051380","article-title":"Retinaldehyde alleviates rosacea","volume":"199","author":"Vienne","year":"1999","journal-title":"Dermatology"},{"issue":"6 Pt 1","key":"10.1016\/j.jaad.2015.02.1121_bib37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","article-title":"A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea","volume":"40","author":"Maddin","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2015.02.1121_bib38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/000155599750009906","article-title":"Double-blind comparison of\u00a0azelaic acid 20% cream and its vehicle in treatment of\u00a0papulo-pustular rosacea","volume":"79","author":"Bjerke","year":"1999","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2015.02.1121_bib39","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archderm.134.6.679","article-title":"Topical metronidazole maintains remissions of rosacea","volume":"134","author":"Dahl","year":"1998","journal-title":"Arch Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215013614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962215013614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:33:48Z","timestamp":1759271628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962215013614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0190962215013614"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2015.02.1121","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of rosacea severity: A review of evaluation methods used in clinical trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2015.02.1121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}